Demonstration of Urokinase Expression in Cancer Cells of Colon Adenocarcinomas by Immunohistochemistry and in Situ Hybridization
Open Access
- 31 October 1999
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 155 (4), 1115-1120
- https://doi.org/10.1016/s0002-9440(10)65214-5
Abstract
No abstract availableKeywords
Funding Information
- Roswell Park Alliance Foundation, Roswell Park Cancer Institute (CA16056)
This publication has 32 references indexed in Scilit:
- Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: An immunohistochemical comparison of normal, benign, and malignant breast tissuesCancer, 1996
- Regional variations of urokinase‐type plasminogen activator in human colorectal cancer: A quantitative study by image analysisInternational Journal of Cancer, 1995
- Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancerHistopathology, 1994
- Location of plasminogen activator (PA) and PA inhibitor in human colorectal adenocarcinomasAPMIS, 1993
- Immunolocalization of urokinase‐type plasminogen activator in adenomas and carcinomas of the colorectumHistopathology, 1991
- Fluorescent Probes as Tools to Assess the Receptor for the Urokinase-Type Plasminogen Activator on Tumor CellsSeminars in Thrombosis and Hemostasis, 1991
- Secretion of plasminogen activators by human colorectal and gastric tumor explantsClinical & Experimental Metastasis, 1988
- Immunohistochemical Localization of Urokinase- and Tissue-Type Plasminogen Activators in Psoriatic SkinJournal of Investigative Dermatology, 1987
- Proteolytic Enzymes in Cancer Invasion and MetastasisSeminars in Thrombosis and Hemostasis, 1986
- Human endothelial cells contain one type of plasminogen activatorFEBS Letters, 1984